TRANSCRIPT

Q4 2020 — Earnings commentary

Q4 2020PDF · 7 pages299 KB
$0.00
$0.50
$1.00
$1.50
$2.00
$0
$350
$700
$1,050
$1,400 CME Group
(consolidated)
4Q 2020
Earnings Commentary
1 	4Q and 2020 Summary
2 	4Q and 2020 Highlights
3 	4Q 2020 Product Detail – Financials
4 	4Q 2020 Product Detail – Commodities
5 	Financial Results & Guidance
6 	Forward Looking Statements
7 	Q&A Conference Call Details
Order of Contents
4Q and 2020 SummaryRevenue
Adjusted Expense*
in millions
Adjusted
Diluted EPS
• Represents quarterly adjusted operating expense excluding licensing and other fee agreements which is the basis for expense guidance
• A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to Non-GAAP
Measures chart at the end of the financial statements
• All growth rates included in this document refer to 4Q20 versus 4Q19, and 2020 versus 2019, unless otherwise noted, and all global data/statistics
exclude the open outcry venue activity
• OI within the chart, and throughout this document, includes only benchmark product within Energy (Crude Oil, Natural Gas and Refined Products)
*
OI in millions*	ADV in millions
Legacy
CME Group
• 	CME Group continued to help clients manage their risk and navigate uncertainty
during 4Q 2020. Activity increased slightly from 3Q20, with 4Q20 average daily
volume (ADV) up 4% and total revenue up 2% sequentially. CME Group’s highly
diverse product set, global distribution, and consistent outreach to market
participants through our salesforce worldwide, positions the company well to
continue to provide risk management opportunities to clients as the trading
environment evolves
• 	2020 total ADV of 19.1 million contracts was just slightly below CME Group’s
record annual volume of 19.2 million contracts in 2018, and included annual
ADV records across Equity Index, Metals and Natural Gas futures and options
• 	Although 4Q20 total ADV of 16.2 million contracts was down from a strong
fourth-quarter last year, ADV grew significantly across a few asset classes
• 4Q20 Equity Index ADV up 58% to 5.1 million contracts including quarterly record
Micro E-mini ADV of 2 million contracts
• 4Q20 Agricultural ADV up 16% to 1.5 million contracts, including regional ADV
records in Europe, Middle East, Africa (EMEA) and Asia Pacific (APAC). In
addition, Soybean futures open interest (OI) reached a record 1.1 million contracts
• 	2020 non-U.S. ADV grew 7% to a record 5.3 million contracts, with double-digit
growth across Equity Index, Agricultural and Metals products. 4Q 2020 non-U.S.
ADV increased 5%, with significant year-over-year growth in Equity Index and
Agricultural Commodities, up 74% and 55%, respectively
• 	Continued to launch/advance innovative new products, tools and services to
support customer needs, and coordinated with customers to execute on the
1Q21 cutover dates for BrokerTec’s migration to CME Globex
• 	Strategic execution led to adjusted net income attributable to CME Group of
$497 million and adjusted diluted earnings per share (EPS) of $1.39
0
40
80
120
0
7
14
21
4Q17 	4Q18 	4Q19 	4Q20

-- 1 of 7 --

-2-
4Q 2020 Earnings Commentary - Unaudited
4Q / 2020 Highlights
Interest Rates
23%
Equity Index
16%
FX
7%
Agricultural
11%
Energy
13%
Metals
5%
Market Data
13%
Other
12%
4Q 2020
Revenue Mix
Includes
Optimization
Includes
BrokerTec (~$40M)
Interest Rate
Swaps Clearing (~$12.3M)
Includes
EBS(~$42M)
CME Group’s highly diverse product set positions the company well for varying macroeconomic backdrops
Continued strength across
Equity Index products
• 4Q20 Equity Index ADV grew
58% to 5.1 million contracts
• E-mini S&P 500 futures and
options up 7% to 2.1 million
contracts
• E-mini Nasdaq 100 futures and
options up 38% to 538,428
contracts
• 4Q20 Micro E-mini record ADV
of 2 million contracts, up 332%,
including
• Record Micro E-mini Nasdaq
100 ADV of 871,145 contracts,
up 404%
• Highest quarterly Micro E-mini
Nasdaq 100 futures ADV out of
APAC and second-highest out
of EMEA
• Second-highest quarterly Micro
E-mini S&P 500 futures and
Micro E-mini Dow futures ADV
out of APAC
• 4Q20 Micro E-mini Options ADV
up 130% sequentially
Agricultural Commodities ADV grew 16%
to 1.5 million contracts
Metals 4Q20 highlights
Despite headwinds, some 4Q20 bright spots in Interest Rates
FX 4Q20 highlights
• Minimum Price Increment (MPI) reductions in AUD/USD futures
helped drive their second-highest volume day on December 9, 2020
of 312,546 contracts or $23.5 billion notional
• After EUR/USD FX futures grew to a record OI level, breaking
through its OI barrier for the 10th time in 2020 and reaching over
828,000 contracts ($121 billion notional) on September 14, 2020,
they reached a new record high 306 large open interest holders
on November 24, 2020
Energy activity picked up
slightly during 4Q20 with ADV
increasing 5% from 3Q20
• Sequential growth in both Crude
Oil and Natural Gas futures and
options, up 7% and 1%
respectively, compared with
3Q20
• Natural Gas options ADV
increased 10% versus 4Q19
• Soybean futures OI reached an all-time high on
October 22, 2020 of 1.1 million contracts, and all
top 10 OI days occurred in October 2020
• Record EMEA ADV of 289,000 contracts, up
48%, and including ADV records across
Soybean, Soybean Oil and Soybean Meal
futures
• Record APAC ADV of 112,000 contracts, up
98%, with record ADV in Soybean, Soybean Oil
and Corn futures
• Agricultural Options ADV grew 55% to
303,000 contracts, including record
Soybean Oil options ADV of 18,000
contracts, up 104%
• 4Q20 Eurodollar futures and options ADV across the back 32 contracts grew 36%
from 4Q19 to 682,131 contracts
• 4Q20 Silver futures and options
ADV up 6% to 104,665 contracts,
including Silver futures ADV up
8% to 97,999 contracts
• 4Q20 Copper futures ADV up 3%
to 87,738 contracts
• 4Q20 Micro Gold futures grew
142% to its second-highest ADV,
and included the second-highest
ADV out of APAC in addition
• 4Q20 Secured Overnight Financing Rate (SOFR) futures ADV grew 63% to a record 69,325 contracts
• December 2020 highlights compared with December 2019:
• SOFR futures grew 91%
• 4Q20 Bitcoin futures ADV grew 106%, and average daily OI reached a record
11,108 contracts (55,540 equivalent bitcoin)
• Ultra 10-Year Treasury Note futures rose 13% 	• Ultra Bond futures increased 14%
2020 Records
• Equity Index futures and options ADV of
5.6 million contracts, up 63%
• E-mini S&P 500 futures/options ADV
of 2.7M contracts
• Micro E-mini futures/options ADV
of 1.8M contracts
• E-mini Nasdaq 100 futures/options
ADV of 596,000 contracts
• SOFR ADV of 51,000 contracts
• Metals ADV of 699,000 contracts – up 5%, 5th consecutive annual record
• Precious metals ADV up 5% to 599,000 contracts, non-U.S. ADV up 11% of
310,000 contracts, and the following annual growth across record ADV
products: Micro Gold up 280%, Micro Silver up 589%, Aluminum futures up
44%, Steel futures up 36%
• Natural Gas futures/options ADV of 639,000 contracts
• Ultra 10-Year U.S. Treasury Note ADV of 255,320 contracts and Ultra U.S.
Treasury Bond ADV of 207,200 contracts
• Soybean Oil futures/options ADV of 141,000 contracts

-- 2 of 7 --

• 2020 non-U.S. ADV highlights:
• Equity Index ADV grew 85% to 1.5 million
contracts
• Agricultural Commodities ADV grew 27% to
382,164 contracts
• Metals ADV grew 11% to 319,346 contracts
• 4Q20 Non-U.S. ADV increased 5% to 4.6
million contracts
• Equity Index up 74% to 1.4 million contracts
• Agricultural Commodities up 55% to
426,345 contracts
• 4Q20 Non-U.S. regional ADV highlights:
• APAC ADV grew 28% with growth across
several asset classes:
• 	Equity Index up 151%
• 	Record Agricultural Commodities up
98%
• 	FX up 29%
• 	Metals up 23%
• EMEA ADV increased 1% with Equity Index
up 54% and record Agricultural
Commodities up 48%
• In Greater Latin America, Metals up 38%,
Equity Index up 26%, and Agricultural
Commodities up 10%
-3-
4Q 2020 Earnings Commentary - Unaudited
Non-U.S. ADV by Product Line
2020 non-U.S. ADV grew 7% to a record 5.3 million contracts, with growth across Equities, Agricultural
Commodities and Metals; 4Q20 non-U.S. ADV up 5%
Non-U.S. % of Total ADV by Product Line
As some economic environments began to improve and as vaccines started to roll out in Q4 2020,
several CME Group asset classes saw some uptick in activity relative to mid-year, with continuing
momentum to date in 2021. CME Group, with its diverse product offering, continues to focus on
factors in its control and assist market participants with their ongoing risk management needs as
the macroeconomic backdrop evolves
• 	4Q20 client engagement up 64% versus the same period last year and full-year sales activity marked CME Group’s
highest year on record, up 112% over 2019, as we adapted to virtual selling and found new and unique ways to
connect with clients
• 	Ended the year with over 1,600 cross-introductions, up from 400 in 2019, and 4Q20 marked our most aggressive
sales campaign slate to date with 16 sales campaigns executed across a range of high-profile products and new
product launches from SOFR to South American Soybeans
• 	Full-year 2020 sales wins were up 15% versus 2019, new client acquisition was up 49%, and we ended 4Q20 with
an all-time high open sales pipeline, which will be aggressively pursued in 2021
4Q20 capped off an outstanding year for client engagement
ADV in millions
0.0
1.0
2.0
3.0
Interest Rates 	Equities 	FX 	Energy 	Agricultural 	Metals
2019 	2020
0%
10%
20%
30%
40%
50%
Interest Rates 	Equities 	FX 	Energy 	Agricultural 	Metals
YTD 2019 	YTD 2020
26%
46%
25% 	27%
46%
28%
Announced formation of leading post-trade services joint venture with IHS Markit
• New company will include trade processing and risk mitigation operations incorporating CME Group’s
optimization businesses – Traiana, TriOptima, and Reset – and IHS Markit’s MarkitSERV
• The combination of these complementary offerings will provide clients with enhanced platforms and
services for global OTC markets across interest rate, FX, equity and credit asset classes. Market participants will
benefit from a more efficient front-to-back workflow with enhanced connectivity and improved trading certainty. As
a result, OTC market participants will be able to improve risk management and streamline post-trade operations

-- 3 of 7 --

-4-
4Q 2020 Earnings Commentary - Unaudited
New Products launched/announced since 4Q20
• 	Nasdaq Veles California Water Index (NQH2O) futures – will help
agricultural, commercial and municipal water users hedge their
exposure to uncertain water prices in California with greater price
discovery and risk management
• 	Ether futures – cash-settled based on the CME CF Ether-Dollar
Reference Rate, which serves as a once-a-day reference rate of
the U.S. dollar price of Ether and listed on and subject to the rules
of CME
• Based on increasing client demand and robust growth in
CME Group’s Bitcoin futures and options
• Ethereum is the second-largest cryptocurrency by both market
capitalization and daily volume
• 	New Japanese Energy futures contracts - four Japanese electricity
futures contracts fill a gap in the Japanese electricity futures market
and two LNG futures contracts provide Japanese power producers
a more efficient tool to manage their price risk
• 	March 2021 launch of Global Emissions Offset (GEO) futures -
pending regulatory review – will provide clients with a market-based
solution to manage global emissions risk. Jointly developed with
Xpansiv market CBL, a leader in spot energy and environmental
markets
• Demand for voluntary carbon offsets is growing around the world
as more countries/companies take action toward creating a lower
carbon economy. This product will provide a regulated, market-
based solution to address risk management needs for near-term
emissions reduction strategies, as well as a standardized pricing
benchmark to help facilitate long-term climate goals
• 	Cobalt futures – Cobalt is a critical building block of the emerging
new energy economy and principal material for the fast-growing
electric vehicle market. Cobalt prices have recovered from 3-year
lows seen in 2019, but are significantly below the 10-year highs
seen in 2018
• 	Pork Cutout futures/options - help clients manage the price risk
associated with hog/pork production and have seen strong ADV
and OI from a wide range of market participants since launch
• 	South American Soybean (Platts) futures (launched in 3Q20) –
addresses the demand of our growing global customer base to
manage South American soybean exposure and to spread against
our existing benchmark Chicago soybeans contract
CME Group continues to launch analytical tools to enhance clients’ experience, along with new products
and services, as well as enhancements to existing offerings
Services or product enhancements launched/
announced since 4Q20
• CME Treasury Watch tool – comprehensive look at
the data shaping cash and futures markets for U.S.
Treasuries today
• BrokerTec Quote – Dealer-to-Client request for
quote (RFQ) trading platform for U.S. Repo market
• FX Market Profile tool – first time market
participants can quantitatively see the benefits of
using both CME Group’s listed and cash FX
marketplaces, with immediate distribution to all EBS
Quantitative Analytics users / FX Options Vol
Converter tool – provides price transparency
between the OTC and CME Options markets –
marked record size block transactions in GBP and
AUD futures since launch
• Began publishing the first CME Group Volatility
Indexes (CVOLTM ) available via CVOL Index
Visualizer tool powered by QuikStrike and through
CME DataMine, with calculations made daily,
providing precise and consistent volatility measure
• Began with 8 implied volatility indexes on CME
Group 10-Year Treasury Note futures (price and
yield) and G5 currency pair futures, and just
added Energy, Metals and Agricultural
benchmarks, as well as additional Fixed Income
indexes
• New Hemp Pricing Data added to CME DataMine,
it’s self-service online data platform, allowing CME
Group market data customers access to benchmark
wholesale hemp pricing data alongside nearly a
petabyte of historical data for futures/options across
every investible asset class, and to test strategies
as well as gauge potential profitability and risks in a
variety of markets
• BrokerTec RV Curve, a way to easily trade pre-
defined spreads on cash U.S. Treasury
benchmarks, to launch in March
• Enabled by the migration to CME Globex, it
eliminates slippage/legging risk, providing a more
efficient way to execute cash Treasury spreads
• New products launched since 2010 generated ~$385 million in revenue in 2020, up 17% from 2019
-
35,000
70,000
105,000
140,000
2014 	2015 	2016 	2017 	2018 	2019 	2020
Metals
Energy
Ags
Commodities	ADV
FinancialsADV New products launched since 2010 	New products launched since 2010
0
700,000
1,400,000
2,100,000
2,800,000
3,500,000
2014 	2015 	2016 	2017 	2018 	2019 	2020
Rates Futures
STIR Options
Treasury Options
Equity Futures
Equity Options
FX Products

-- 4 of 7 --

4Q 2020 Product Detail - Financials
-5-
OI
in millions
ADV
in millions
Interest Rates
ADV 	OI
Equities 	OI
in millions
ADV
in millions
ADV 	OI
FX 	OI
in millions
ADV
in millions
ADV 	OI
4Q 2020 Earnings Commentary - Unaudited
4Q 2020 Product Detail - Commodities
Energy 	OI*
in millions
ADV
in millions
ADV 	OI*
Agricultural 	OI
in millions
ADV
in millions
ADV 	OI
Metals 	OI
in millions
ADV
in millions
ADV 	OI
*OI includes benchmark product areas only –
Crude Oil, Natural Gas and Refined
0
30
60
90
120
0
4
8
12
0
5
10
15
0
2
4
6
1
2
3
4
0.0
0.3
0.6
0.9
1.2
0
5
10
15
20
0.0
0.7
1.4
2.1
2.8
0.0
2.5
5.0
7.5
10.0
0.0
0.4
0.8
1.2
1.6
1
2
3
4
0.00
0.20
0.40
0.60
0.80
Integration Progress
• Completed the migration of BrokerTec earlier in February, with the US Treasury Actives, US Repo, EU Repo and EU
government bonds businesses now available on our CME Globex technology. Clients now have an enhanced suite of
government bond trading offerings across listed derivatives, cash and repo markets on a common platform and will result
in greater operational and technology efficiencies for the marketplace to manage risk. As a part of the migration, the
existing BrokerTec Global Front End (GFE) application has been integrated into CME Globex, and real-time BrokerTec
data can be streamed with CME Group futures and options data for users of the CME Market Data platform
• Global client outreach has continued ahead of the scheduled migration of EBS, planned for Q4 2021
• Completed winddown process for non-North American trade repositories and European regulatory reporting businesses
• Will complete the third phase of a three-year process of staffing the combined company later this year

-- 5 of 7 --

• 4Q20 revenue was $1.1 billion
• 4Q20 clearing and transaction fees revenue totaled $843 million,
including approximately $105 million from cash markets and
optimization services businesses. EBS generated $42 million of
transaction revenue during the quarter and BrokerTec generated
$40 million
• Overall 4Q20 futures and options RPC was 69.9 cents, down
from 71.6 cents in 3Q20, primarily due to a sequential increase in
ADV and a higher proportion of member participation. The
proportion of the Equity Index volume made up by the lower
priced and very popular micro E-mini equity contracts was 39%,
compared with 36% in 3Q20. Micro E-mini ADV averaged a
record 2 million contracts per day in 4Q20, up 2% from 3Q20.
The micro E-mini average RPC for 4Q20 was approximately 14
cents. In addition, 4Q20 Micro Gold ADV of 76,000 contracts
made up 13% of total Metals ADV, down from 17% of the total in
3Q20. The Micro Gold average RPC for 4Q20 was approximately
32.4 cents
• Market Data revenue in 4Q20 was a record $140 million, up 7%
compared with 4Q19, driven by increased demand for CME
Group data to be used in automated trading solutions, and
increased usage of CME Group data as inputs into the
development of new derivative financial products and services
• 4Q20 Other revenue was $116 million, up 8% from 4Q19
• 4Q20 adjusted expense, excluding license fees, was $405.5
million, down 3% from $418.9 million in 4Q19. For the full-year,
this totaled $1.557 billion, approximately $90 million below the
mid-point of our original guidance, and $80 million below 2019
• 4Q20 adjusted non-operating income was $13.0 million, down
from $29.4 million in 4Q19. In the first quarter, we mentioned the
Federal Reserve’s mid-March reduction in interest on excess
reserves to 10 basis points and CME Group’s retaining 2 basis
points commensurate with that reduction. Higher cash balances
and a shift to higher yielding investments helped partially offset
lower CME Group returns
• The adjusted 4Q20 effective tax rate was 23.2%
• Adjusted net income attributable to CME Group was $497 million
and adjusted diluted EPS were $1.39
• Capital expenditures for 4Q20 totaled $69 million, including $4
million of leasehold improvements, the majority of which will be
reimbursed over time, and approximately $11 million in one-time
capital expenditures associated with the integration. For the
full-year, capital expenditures totaled $193 million
• As of December 31, the company had approximately $1.7 billion
in cash (including $100 million deposited with Fixed Income
Clearing Corporation (FICC) and included in other current assets)
and $3.4 billion of debt. The company declared dividends during
2020 of $2.1 billion, including the annual variable dividend for
2020 of $895 million. The company has returned over $15.3
billion to shareholders in the form of dividends since
implementing the variable dividend policy in early 2012
Financial Results
Notes & Guidance – Full Year 2021
-6-
Regular Quarterly
Dividend
Annual Variable
Dividend
Dividends Paid* $ in millions
*Annual, variable dividend reflecting excess cash from 2011
was paid in 1Q 2012, and annual, variable dividend reflecting
excess cash from 2012 (which is illustrated in 2013 on this
chart), was paid early in 4Q 2012
4Q 2020 Earnings Commentary - Unaudited
• Adjusted operating expense excluding license
fees expected to be approximately $1.575
billion
• Capital expenditures, net of leasehold
improvement allowances and any one-time
costs associated with the integration, expected
to be between $180 million and $190 million
• Adjusted effective tax rate expected to be
between 23.2% and 24.2%
• At the end of 2020, the company reached
$132 million in run rate expense synergies
and $8 million in subleasing revenue synergies
for a total of $140 million. At the end of 2021,
we expect cumulative run rate synergies to be
at $200 million and expect to realize
approximately $35 million in P&L impact
during the year
$0
$500
$1,000
$1,500
$2,000
$2,500
• Last week, CME Group declared a first-
quarter dividend of $0.90 per share, a 6%
increase from the prior regular quarterly
dividend level of $0.85 per share

-- 6 of 7 --

Statements in this document that are not historical facts are forward-looking statements. These statements are not guarantees
of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes
and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you
not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-
looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our
performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into
our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers
while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue
introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading
capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide
effective services to the swaps market; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to
maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our
ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in
laws or government policies with respect to our products or services or our industry, such as any changes to regulations and
policies that require increased financial and operational resources from us or our customers; the costs associated with protecting
our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others;
decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions;
changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers
(whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the
impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us
from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements
associated with the BrokerTec matched principal business; the ability of our compliance and risk management methods to
effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure
against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and
exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by
our third-party providers; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and
instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange rates;
economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of
economic conditions on the trading activity of our current and potential customers; the impact of the COVID-19 pandemic and
response by governments and other third parties; our ability to accommodate increases in contract volume and order transaction
traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems;
our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs
and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated
with NEX; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our
business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax or
user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; our ability to maintain
our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional
information concerning these and other factors that might affect our performance, see our filings with the Securities and
Exchange Commission, including our most recent periodic reports files on Form 10-K and Form 10-Q.
Q&A Conference Call Details:
CME Group will hold a live Q&A teleconference to take questions related to fourth-quarter 2020 results at 8:30 a.m.
Eastern Time today. A live audio Webcast of the Q&A teleconference will be available on the Investor Relations section of
CME Group’s Web site, www.cmegroup.com. Following the conference call, an archived recording will be available at the
same site. Those wishing to listen to the live Q&A teleconference via telephone should dial 1-800-437-2398 if calling from
within the United States or +1-323-289-6576 if calling from outside the United States, at least 10 minutes before the call
begins.
Analysts and investors are encouraged to review the Company’s recent filings with the U.S. Securities and Exchange
Commission, as well as the quarterly earnings reference documents posted to the Investor Relations page of CME
Group’s Web site.
-7-
Use of Non-GAAP Measures
Forward-Looking Statements
A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the
Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation
materials posted in the same area of the Investor Relations page on CME Group’s Web site at www.cmegroup.com.
4Q 2020 Earnings Commentary - Unaudited

-- 7 of 7 --